WALKER C MAY
Allopathic & Osteopathic Physicians|Family Medicine VIVIAN, LA NPI 1003083205
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine LA Lilly USA, LLC All categories
General Payments — all program years on this page
$1,997.02
- Category: General Payments
- Program years: PY2018–2024
- Record count: 109
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $136.07 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $136.07 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $32.13 | 2 |
| Mylan Specialty L.P. | $23.31 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.82 | 1 |
| Acerta Pharma LLC | $17.44 | 1 |
| PFIZER INC. | $15.86 | 1 |
| Exact Sciences Corporation | $14.90 | 1 |
| INOGEN, INC. | $9.61 | 2 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104515660 | AstraZeneca Pharmaceuticals LP | $17.44 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114777875 | Exact Sciences Corporation | $14.90 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117831155 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22.82 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131857474 | PFIZER INC. | $15.86 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135452865 | Lilly USA, LLC | $17.69 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135468075 | Lilly USA, LLC | $14.44 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144988635 | INOGEN, INC. | $8.42 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144988637 | INOGEN, INC. | $1.19 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147304667 | Mylan Specialty L.P. | $23.31 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.